Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cassava Sciences Inc
(NQ:
SAVA
)
29.04
+0.04 (+0.14%)
Streaming Delayed Price
Updated: 10:19 AM EDT, Oct 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cassava Sciences Inc
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Cassava Sciences Stock Has Plenty of Momentum After Positive Clinical Data
July 29, 2021
As Cassava Sciences made progress in treating Alzheimer's, SAVA stock is on a powerful path to significantly higher prices.
Via
InvestorPlace
Here's Why Annovis Bio, Anavex Life Sciences, and Cassava Sciences Sank on Thursday
July 29, 2021
A clinical-trial flop for Annovis Bio is reminding investors that developing new drugs for Alzheimer's disease is an extremely risky business.
Via
The Motley Fool
Understanding Cassava Sciences's Unusual Options Activity
July 29, 2021
Cassava Sciences (NASDAQ:SAVA) shares experienced unusual options activity on Thursday. The stock price moved down to $107.95 following the option alert. Sentiment: BEARISH...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 29, 2021
Gainers NanoVibronix (NASDAQ:NAOV) share...
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
July 29, 2021
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 47.6% to $2.8198 after the company announced it received registration approval for UroShield from TGA Australia....
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; Mastercard Profit Beats Estimates
July 29, 2021
Following the market opening Thursday, the Dow traded up 0.44% to 35,085.92 while the NASDAQ rose 0.27% to 14,802.51. The S&P also rose, gaining 0.45% to 4,420.49. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stocks That Hit 52-Week Highs On Thursday
July 29, 2021
Thursday's morning session saw 167 companies set new 52-week highs. Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by market cap to set a new...
Via
Benzinga
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 29, 2021
Gainers Cocrystal Pharma (NASDAQ:COCP) stock moved upwards by 30.9% to $1.44 during Thursday's pre-market session. The company's market cap stands at $140.3...
Via
Benzinga
Should You Invest in This Seemingly Unstoppable Alzheimer's Biotech?
July 29, 2021
This popular life science company has a fair but risky shot of developing a novel drug to treat Alzheimer's disease.
Via
The Motley Fool
Cassava Sciences Stock Looks Ready To Break Out If This Pattern Is Confirmed
July 26, 2021
Cassava Sciences Inc. (NASDAQ: SAVA) shares were moving Monday after the company announced positive clinical data with SavaDx. SavaDx is an investigational diagnostic to...
Via
Benzinga
Don't Get Faked Out By The Fear & Greed Index
July 25, 2021
False positives can prevent gains. Consider another approach.
Via
Talk Markets
Cassava Sciences Stock Could Be Worth $900 After Its Upcoming Alzheimer’s Results
July 23, 2021
Cassava Sciences stock could jump with its upcoming Alzheimer's results. SAVA stock options show the lofty expectations investors have.
Via
InvestorPlace
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
July 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...
Via
Benzinga
Stocks That Hit 52-Week Highs On Monday
July 26, 2021
This morning 121 companies reached new 52-week highs. Areas of Significance: Alphabet (NASDAQ:GOOGL) was the largest company by market cap to set a new 52-week high...
Via
Benzinga
An Unforgettable Week For Alzheimer's Treatment Stocks: Two Of Our Recent Top Names Spike On News Of Potentially Promising Treatments
July 23, 2021
Screen capture via IGC's healthcare subsidiary Hyalolex. "Drops of Clarity" is their just-patented Alzheimer's treatment. Two Stocks Spike On Alzheimer...
Via
Benzinga
Update On A Bear-Proof Portfolio: The Portfolio We Presented Earlier This Week Is Off To A Fast Start
July 23, 2021
Japanese gameshow contestant versus bear. Image via TMZ. Bear-Proof Portfolio Update Here's the "bear-proof" portfolio we presented in our pre-market post on...
Via
Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
Why Annovis Stock Is Bucking The Trend In Alzheimer's — And Two Others To Watch
July 23, 2021
Annovis bucked the trend depressing Alzheimer's stocks on Friday as ANVS stock touched a record high while SAVA stock and INMB stock fell.
Via
Investor's Business Daily
An Unforgettable Week For Alzheimer's Treatment Stocks
July 23, 2021
Two of our recent top stocks spiked on news of potentially promising Alzheimer's treatments this week. They're both risky names, so we look at how to hold them without losing your shirt.
Via
Talk Markets
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
July 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (...
Via
Benzinga
Cassava Sciences Stock Soars In Anticipation Of Alzheimer's Data: A Technical Analysis
July 22, 2021
On Thursday, Cassava Sciences, Inc (NASDAQ: SAVA) smashed through a resistance level at $117.54, made 21 years ago between its initial public offering date of June 14,...
Via
Benzinga
Update On A Bear-Proof Portfolio
July 22, 2021
A quick update on the portfolio we presented here in our pre-market post on Tuesday.
Via
Talk Markets
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
July 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical...
Via
Benzinga
Exposures
Product Safety
2 High-Risk, High-Reward Stocks That Could Go to the Moon
July 22, 2021
Risk-averse investors may want to look elsewhere.
Via
The Motley Fool
61 Biggest Movers From Yesterday
July 22, 2021
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares surged 159.2% to close at $5.34 on Wednesday after the company received a $28.3 million purchase order from Brazil's...
Via
Benzinga
Here's Why Cassava Sciences Is Surging Today
July 21, 2021
Investors are excited about upcoming presentations scheduled for the annual Alzheimer's Association International Conference.
Via
The Motley Fool
Exposures
Product Safety
SAVA Stock: Two Dates Cassava Investors Need to Mark on Their Calendars
July 21, 2021
SAVA stock is flying upward today as investors clamor to hear information around two new products. Investors should save two upcoming dates.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 21, 2021
Gainers Chembio Diagnostics (NASDAQ:CEMI) stock rose 189.72% to $5.97 during Wednesday's regular session. Trading volume for Chembio Diagnostics's stock is 265.3...
Via
Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
July 21, 2021
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to...
Via
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.